Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for BCYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 510.05M
March 31, 2026 560.02M
December 31, 2025 628.66M
September 30, 2025 648.32M
June 30, 2025 721.45M
March 31, 2025 792.97M
December 31, 2024 879.52M
September 30, 2024 890.86M
June 30, 2024 961.36M
March 31, 2024 457.00M
December 31, 2023 526.42M
September 30, 2023 572.09M
June 30, 2023 340.43M
March 31, 2023 293.82M
December 31, 2022 339.15M
September 30, 2022 361.47M
June 30, 2022 372.77M
March 31, 2022 407.37M
Date Value
December 31, 2021 438.68M
September 30, 2021 259.52M
June 30, 2021 198.74M
March 31, 2021 195.90M
December 31, 2020 135.99M
September 30, 2020 149.84M
June 30, 2020 96.91M
March 31, 2020 109.64M
December 31, 2019 92.12M
September 30, 2019 95.95M
June 30, 2019 108.54M
March 31, 2019 59.36M
December 31, 2018 63.38M
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017 67.66M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Autolus Therapeutics Plc 203.13M
Akari Therapeutics Plc 7.754M
Biodexa Pharmaceuticals Plc --
DBV Technologies SA --
Cellectis SA 166.85M